NO20060093L - Plate glykoprotein IB alfa-variant fusjonspolypeptider og fremgangsmater for anvendelse derav - Google Patents
Plate glykoprotein IB alfa-variant fusjonspolypeptider og fremgangsmater for anvendelse deravInfo
- Publication number
- NO20060093L NO20060093L NO20060093A NO20060093A NO20060093L NO 20060093 L NO20060093 L NO 20060093L NO 20060093 A NO20060093 A NO 20060093A NO 20060093 A NO20060093 A NO 20060093A NO 20060093 L NO20060093 L NO 20060093L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- glycoprotein
- plate
- fusion polypeptides
- variant fusion
- Prior art date
Links
- 102000023159 Platelet Glycoprotein GPIb-IX Complex Human genes 0.000 title 1
- 108010045766 Platelet Glycoprotein GPIb-IX Complex Proteins 0.000 title 1
- 230000004927 fusion Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47752503P | 2003-06-11 | 2003-06-11 | |
PCT/US2004/019057 WO2004111089A2 (en) | 2003-06-11 | 2004-06-14 | Platelet glycoprotein ib alpha variant fusion polypeptides and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20060093L true NO20060093L (no) | 2006-03-01 |
Family
ID=33551724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20060093A NO20060093L (no) | 2003-06-11 | 2006-01-06 | Plate glykoprotein IB alfa-variant fusjonspolypeptider og fremgangsmater for anvendelse derav |
Country Status (16)
Country | Link |
---|---|
US (2) | US7727535B2 (ru) |
EP (2) | EP1636266A2 (ru) |
JP (1) | JP2007537710A (ru) |
KR (1) | KR20060022261A (ru) |
CN (1) | CN100436480C (ru) |
AU (1) | AU2004247737B2 (ru) |
BR (1) | BRPI0411289A (ru) |
CA (1) | CA2530972A1 (ru) |
HK (1) | HK1095152A1 (ru) |
IL (2) | IL172337A (ru) |
MX (1) | MXPA05013509A (ru) |
NO (1) | NO20060093L (ru) |
NZ (1) | NZ544165A (ru) |
RU (1) | RU2403262C2 (ru) |
WO (1) | WO2004111089A2 (ru) |
ZA (1) | ZA200510331B (ru) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7534595B2 (en) * | 2006-06-12 | 2009-05-19 | Biomarin Pharmaceutical Inc. | Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof |
US11535673B2 (en) * | 2007-04-05 | 2022-12-27 | President and Fellows of Harvard CoHege | Chimeric activators: quantitatively designed protein therapeutics and uses thereof |
DE102007031708A1 (de) * | 2007-07-06 | 2009-01-08 | Dade Behring Marburg Gmbh | Bestimmung der von Willebrand Faktor-Aktivität in Abwesenheit von Ristocetin |
EP2193373A4 (en) | 2007-08-23 | 2010-07-28 | Bloodct Of Wisconsin Inc | METHODS AND KITS FOR MEASURING VON WILLEBRAND FACTOR |
EP2750690B1 (en) * | 2011-11-15 | 2018-11-07 | The Walter and Eliza Hall Institute of Medical Research | Soluble mediator |
EP2794007A4 (en) * | 2011-12-23 | 2015-11-18 | Vasculogics Inc | COMPOSITIONS AND METHODS FOR TREATING THROMBOSES AND EXTENDING THE LIFE OF THE STORED THROMBOCYTES |
EP2919013B1 (de) * | 2014-03-11 | 2016-11-02 | Siemens Healthcare Diagnostics Products GmbH | Verfahren zur Detektion von Modulatoren der GPIb-Thrombin-Interaktion |
US10308697B2 (en) | 2014-04-30 | 2019-06-04 | President And Fellows Of Harvard College | Fusion proteins for treating cancer and related methods |
EP3164417A1 (en) | 2014-07-01 | 2017-05-10 | Pfizer Inc. | Bispecific heterodimeric diabodies and uses thereof |
TW202000692A (zh) * | 2018-02-20 | 2020-01-01 | 美商格里佛診斷方法股份有限公司 | 包含GpIbα的多肽和組合物、編碼該多肽的核酸及包含該多肽或該核酸的細胞 |
CN113264995A (zh) * | 2021-05-26 | 2021-08-17 | 苏州大学 | 一种血小板GPIbα蛋白相关的抗原表位肽及其应用 |
WO2023007182A1 (en) * | 2021-07-29 | 2023-02-02 | The University Of Birmingham | Protein interaction inhibitors |
WO2023109903A1 (zh) * | 2021-12-15 | 2023-06-22 | 上海循曜生物科技有限公司 | 治疗血小板减少的产品及方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL88308A0 (en) * | 1987-11-17 | 1989-06-30 | Scripps Clinic Res | Peptides that block the binding of von willebrand factor |
US5340727A (en) | 1987-11-17 | 1994-08-23 | The Scripps Research Institute | GPIbα fragments and recombinant DNA expression vectors |
US4899195A (en) * | 1988-01-29 | 1990-02-06 | Ushio Denki | Method of exposing a peripheral part of wafer |
US5225538A (en) | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5194743A (en) * | 1990-04-06 | 1993-03-16 | Nikon Corporation | Device for positioning circular semiconductor wafers |
JP2874280B2 (ja) * | 1990-05-16 | 1999-03-24 | 株式会社ニコン | 周縁露光装置及び周縁露光方法 |
US6136310A (en) | 1991-07-25 | 2000-10-24 | Idec Pharmaceuticals Corporation | Recombinant anti-CD4 antibodies for human therapy |
US5317097A (en) | 1991-10-07 | 1994-05-31 | The Research Foundation Of State University Of New York | Mutations in the gene encoding the α chain on platelet glycoprotein IB |
US6277975B1 (en) | 1992-10-23 | 2001-08-21 | Genetics Institute, Inc. | Fusions of P-selectin ligand protein and polynucleotides encoding same |
US5516964A (en) | 1994-01-21 | 1996-05-14 | Sun Company, Inc. (R&M) | Hydrocarbon isomerization using solid superacid catalysts comprising platinum metal |
TW316322B (ru) * | 1995-10-02 | 1997-09-21 | Ushio Electric Inc | |
JP3237522B2 (ja) * | 1996-02-05 | 2001-12-10 | ウシオ電機株式会社 | ウエハ周辺露光方法および装置 |
JP3735921B2 (ja) | 1996-02-07 | 2006-01-18 | 三菱ウェルファーマ株式会社 | GPIb・脂質複合体およびその用途 |
JP2002510481A (ja) | 1998-04-02 | 2002-04-09 | ジェネンテック・インコーポレーテッド | 抗体変異体及びその断片 |
WO1999054360A1 (fr) | 1998-04-23 | 1999-10-28 | Ajinomoto Co., Inc. | Substance possedant une activite antithrombotique et procede de detection de glycokallidine |
AR035779A1 (es) | 2001-02-06 | 2004-07-14 | Genetics Inst Llc | Polipeptidos de fusion derivados de glicoproteina ib alfa de plaqueta y metodos de uso de los mismos |
-
2004
- 2004-06-14 WO PCT/US2004/019057 patent/WO2004111089A2/en active Application Filing
- 2004-06-14 NZ NZ544165A patent/NZ544165A/en not_active IP Right Cessation
- 2004-06-14 BR BRPI0411289-0A patent/BRPI0411289A/pt not_active IP Right Cessation
- 2004-06-14 AU AU2004247737A patent/AU2004247737B2/en not_active Ceased
- 2004-06-14 EP EP04776599A patent/EP1636266A2/en not_active Withdrawn
- 2004-06-14 US US10/868,371 patent/US7727535B2/en not_active Expired - Fee Related
- 2004-06-14 CN CNB2004800199433A patent/CN100436480C/zh not_active Expired - Fee Related
- 2004-06-14 RU RU2006100306/10A patent/RU2403262C2/ru not_active IP Right Cessation
- 2004-06-14 MX MXPA05013509A patent/MXPA05013509A/es active IP Right Grant
- 2004-06-14 JP JP2006533797A patent/JP2007537710A/ja active Pending
- 2004-06-14 CA CA002530972A patent/CA2530972A1/en not_active Abandoned
- 2004-06-14 EP EP12174152A patent/EP2522677A1/en not_active Withdrawn
- 2004-06-14 ZA ZA200510331A patent/ZA200510331B/xx unknown
- 2004-06-14 KR KR1020057023647A patent/KR20060022261A/ko not_active Application Discontinuation
-
2005
- 2005-12-02 IL IL172337A patent/IL172337A/en not_active IP Right Cessation
-
2006
- 2006-01-06 NO NO20060093A patent/NO20060093L/no not_active Application Discontinuation
-
2007
- 2007-02-22 HK HK07102003.4A patent/HK1095152A1/xx not_active IP Right Cessation
-
2009
- 2009-11-19 US US12/621,887 patent/US20110039780A1/en not_active Abandoned
-
2012
- 2012-06-10 IL IL220272A patent/IL220272A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20060022261A (ko) | 2006-03-09 |
CN100436480C (zh) | 2008-11-26 |
WO2004111089A2 (en) | 2004-12-23 |
AU2004247737B2 (en) | 2009-04-23 |
BRPI0411289A (pt) | 2006-08-01 |
JP2007537710A (ja) | 2007-12-27 |
NZ544165A (en) | 2008-12-24 |
RU2403262C2 (ru) | 2010-11-10 |
WO2004111089A3 (en) | 2005-05-12 |
EP2522677A1 (en) | 2012-11-14 |
ZA200510331B (en) | 2007-03-28 |
AU2004247737A1 (en) | 2004-12-23 |
US20110039780A1 (en) | 2011-02-17 |
EP1636266A2 (en) | 2006-03-22 |
US7727535B2 (en) | 2010-06-01 |
RU2006100306A (ru) | 2006-06-10 |
CN1823090A (zh) | 2006-08-23 |
IL172337A (en) | 2012-07-31 |
IL220272A0 (en) | 2012-07-31 |
US20050089888A1 (en) | 2005-04-28 |
HK1095152A1 (en) | 2007-04-27 |
MXPA05013509A (es) | 2006-04-05 |
CA2530972A1 (en) | 2004-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20060093L (no) | Plate glykoprotein IB alfa-variant fusjonspolypeptider og fremgangsmater for anvendelse derav | |
IL245462A0 (en) | Antagonists of human origin against cmet | |
SG158141A1 (en) | Pancreatic polypeptide family motifs, polypeptides and methods comprising the same | |
ATE350409T1 (de) | Ampholytisches copolymer und dessen verwendung | |
BRPI0507118A (pt) | polipeptìdeos de interferon humano modificado e seus usos | |
ATE461217T1 (de) | Glp-1-verbindungen | |
GB0700909D0 (en) | Novel antigen-binding polypeptides and their uses | |
MX2007002675A (es) | Antagonistas anti-beta7 humanizados y usos para los mismos. | |
UA89734C2 (en) | ANTAGONISTS of muscarinic acetylcholine receptors | |
YU9404A (sh) | Multimerna, usmerena kontrastna sredstva na bazi peptida | |
ATE554114T1 (de) | Copolymer mit zwitterionischen einheiten und anderen einheiten, das copolymer umfassende zusammensetzung und verwendung | |
NO20034056D0 (no) | Proliferative sykdommer | |
DK1487493T3 (da) | Konjugater af cytotoksiske midler og biologisk aktive peptider | |
ID26984A (id) | Senyawa-senyawa sulfonamida sebagai antagonis reseptor angiotensin endotelin ganda | |
DE602005026169D1 (de) | Tetrahydroisochinolinverbindungen zur behandlung von zns-erkrankungen | |
DK1899334T3 (da) | Naphthyridinforbindelser | |
WO2003104425A3 (en) | NEW STABLE ANTI-CD22 ANTIBODIES | |
SE9904377D0 (sv) | Pharmaceutical combinations | |
DE60312211D1 (de) | Haarbehandlungsmittel | |
SE0301650D0 (sv) | Novel compounds | |
MXPA03010684A (es) | Peptidos y el uso de los mismos para oscurecer la piel. | |
NO20011537L (no) | Chemokin-reseptorpeptidvaksiner for behandling og forebygging av diabetes | |
WO2002063003A3 (en) | Platlet glycoprotein ib alpha fusion polypeptides and methods of use thereof | |
WO2007034490A3 (en) | Diastereomeric peptides for modulating t cell immunity | |
ATE363511T1 (de) | Trennfilme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |